Cadisegliatin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cadisegliatin, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes [Phase 3]